Shoulder Innovations initiated a limited user release of its next-generation InSet Go glenoid implant for anatomic shoulder arthroplasty procedures. The launch follows the successful completion of the company's first surgical case, performed by Dr. Robert Gillespie at University Hospitals Cleveland Medical Center on October 8, 2026. The InSet Go maintains the original design principle of imprinting the implant within a circumferential rim of hard bone to eliminate loosening while streamlining the operating room experience and reducing procedure times. CEO Rob Ball noted robust commercial response and anticipated full commercial introduction in coming quarters. Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market with advanced implant systems for shoulder arthroplasty.
